9th Annual MarketsandMarkets

Biomarker and Companion Diagnostics Conference - West Coast Edition

8th - 9th February 2024

Double Tree by Hilton, San Diego - Mission Valley | 7450 Hazard Centre Drive San Diego, CA

Leveraging next gen technologies beyond conventional biomarker drug discovery!

MarketsandMarkets bring to you the 9th Annual Biomarker and CDx Conference - West Coast Edition scheduled to be held on 8th - 9th February 2024 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

Tag Line
30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research and Future of Companion Diagnostics
Tag Line
Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
Tag Line
Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.

The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

CO-LOCATED CONFERENCES

MarketsandMarkets Next-Gen Immuno-Oncology Conference - West Coast Edition
6th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference

WHAT TO EXPECT

  • Commercialization of CDx
  • Proteomics and Genomics based Biomarkers
  • Biomarker Drug Discovery and Assay Development
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
  • Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development
  • Personalized Medicine
  • Immunology Biomarkers

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening Remarks from the Chairperson

Jim Kean

Jim Kean, Chief Executive Officer, Molecular You

08:55 - 09:00

BIOMARKER DRUG DISCOVERY AND ASSAY VALIDATION

Keynote Presentation :Enhanced Biomarker Discovery and Validation Using TMT® Proteomics

Ian Pike

Ian Pike, Chief Scientific Officer, Proteome Sciences PLC

09:00 - 09:30

Spatial Analysis in Ulcerative Colitis and Crohn’s Disease

Jiangwei Zhang

Jiangwei Zhang, Senior Principal Scientist, Bristol Myers Squibb

09:30 - 10:00

Development of Methylation and Mutation Panel for Colorectal Cancer

Collin Hidzik

Collin Hidzik, Scientist in product and business development , EpigenDx

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Next Gen Proteomics identified protein signatures for early pan cancer detection and stratification

Kathy Nevola

Kathy Nevola, Data Scientist, Olink

11:15 - 11:45

Flow cytometry for biomarker development, clinical trial assays, MRD, and CDx

Scott J. Bornheimer

Scott J. Bornheimer, Associate Director, Medical & Scientific Affairs, BD Biosciences

11:45 - 12:15

AI and Multimoodal Biomarkers for Personalized Pain Medicine

Carl Saab

Carl Saab, Professor, Innovation Lead Digital Health, Cleveland Clinic

12:15 - 12:45

Identification of cancer cell surface target for antibody drug conjugate development.

Ginette Serrero

Ginette Serrero, Chief Executive Officer, A&G Pharmaceutical, Inc. | Precision Antibody

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Role of biomarkers in personalized medicine Identifying Variants Associated with Creatinine and Cystatin C Serum Levels in the Top 1% of the Population Provides Insight into the Genetic Architecture of Kidney Function and Chronic Kidney Disease.

Matteo D’Antonio

Matteo D’Antonio, Assistant Professor, University of California, San Diego

14:15 - 14:45

Innovative oncology liquid biopsy testing in global markets, from lab testing to CDx

Myles A. Walsh

Myles A. Walsh, Director of Business Development, Predicine

14:45 - 15:15

Microbial Marvels: Unleashing Targeted Drug Discovery with Pragma Bios Innovative Approach to Disease-Associated Small Molecules and Novel Biomarkers

Kareem Barghouti

Kareem Barghouti, CEO, Pragma Bio

15:15 - 15:45

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:45 - 16:30

AI-powered multi-omic health analytics

Jim Kean

Jim Kean, Chief Executive Officer, Molecular You

16:30 - 17:00

Closing Remarks from the Chairperson

Jim Kean

Jim Kean, Chief Executive Officer, Molecular You

17:00 - 17:30

Drinks Reception & Networking

17:30 - 17:30

End of Day 1

17:30 - 17:30

Registration

08:15 - 09:00

Welcome note from MarketsandMarkets

09:00 - 09:05

Opening Remarks from the Chairperson

Jim Kean

Jim Kean, Chief Executive Officer, Molecular You

09:05 - 09:10

FROM BIOMARKERS TO CDX: STRATEGIES TO ACCELERATE CDX DEVELOPMENT AND COMMERCIALIZATION

Keynote Presentation Bringing AI to Companion Diagnostics

Ken Bloom

Ken Bloom , Head of Pathology, Nucleai

09:10 - 09:45

The crucial role of biospecimen management in precision medicine

Ayat Alsaraby

Ayat Alsaraby, Sr. Manager, Clinical Biomarker, Repare Therapeutics

09:45 - 10:20

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:20 - 11:05

Opportunities for biomarker development in neuroscience

Pablo Lapuerta

Pablo Lapuerta, Chief Executive Officer, 4M Therapeutics Inc.

11:05 - 11:40

Identifying underlying mechanisms of neurological conditions with multi-omic biomarker analysis

Rob Fraser

Rob Fraser, Chief Scientific Officer, Molecular You

11:40 - 12:15

Panel Discussion: Biomarker Revolution: Enhancing Patient Care Across Specialties

Nicole Miller

Nicole Miller, Vice President, Molecular Diagnostics Global Medical Affairs, Ultragenyx

Ken Bloom

Ken Bloom , Head of Pathology, Nucleai

 Julius Goepp

Julius Goepp, CEO, Evimero

Pablo Lapuerta

Pablo Lapuerta, Chief Executive Officer, 4M Therapeutics Inc.

12:15 - 13:00

Lunch and Poster Presentation | One-to-One Networking Meetings

13:00 - 13:30

End of the conference

13:30 - 13:30

SPEAKERS

Collin Hidzik

Collin Hidzik

Scientist in product and business development , EpigenDx

Rob Fraser

Rob Fraser

Chief Scientific Officer, Molecular You

Ken Bloom

Ken Bloom

Head of Pathology, Nucleai

Ian Pike

Ian Pike

Chief Scientific Officer, Proteome Sciences PLC

Arvind Rao

Arvind Rao

Associate Professor of Computational Medicine and Bioinformatics, Department of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor

Jim Kean

Jim Kean

Chief Executive Officer, Molecular You

Kareem Barghouti

Kareem Barghouti

CEO, Pragma Bio

Ginette Serrero

Ginette Serrero

Chief Executive Officer, A&G Pharmaceutical, Inc. | Precision Antibody

Kathy Nevola

Kathy Nevola

Data Scientist, Olink

Myles A. Walsh

Myles A. Walsh

Director of Business Development, Predicine

Ayat Alsaraby

Ayat Alsaraby

Sr. Manager, Clinical Biomarker, Repare Therapeutics

Matteo D’Antonio

Matteo D’Antonio

Assistant Professor, University of California, San Diego

 Julius Goepp

Julius Goepp

CEO, Evimero

Pablo Lapuerta

Pablo Lapuerta

Chief Executive Officer, 4M Therapeutics Inc.

Nicole Miller

Nicole Miller

Vice President, Molecular Diagnostics Global Medical Affairs, Ultragenyx

Carl Saab

Carl Saab

Professor, Innovation Lead Digital Health, Cleveland Clinic

Jiangwei Zhang

Jiangwei Zhang

Senior Principal Scientist, Bristol Myers Squibb

Scott J. Bornheimer

Scott J. Bornheimer

Associate Director, Medical & Scientific Affairs, BD Biosciences

ENQUIRE NOW

SPONSORS

LOCATION

Venue

Double Tree by Hilton, San Diego - Mission Valley | 7450 Hazard Centre Drive San Diego, CA

PAST EVENT GALLERY